EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study

Alejandra Flores Legarreta iD, Gloria Salvo iD, Naomi R Gonzales iD, Gary Chisholm iD, R Tyler Hillman iD, Michael Frumovitz iD

Journal of Gynecologic Oncology · 2023

DOI: 10.3802/jgo.2023.34.e50 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2023. Verfasst von Alejandra Flores Legarreta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. aflegarreta@mdande…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To describe the gene alteration status in high-grade neuroendocrine cervical carcinoma (NECC) specimens and to explore the potential association of unique gene alterations with survival. METHODS: Results from tumor-based molecular testing on specimens from women with high-grade NECC in the Neuroendocrine Cervical Tumor Registry were reviewed and analyzed. Tumor specimens could be from primary or metastatic sites and obtained at initial diagnosis, during treatment, or at recurrence. RESULTS: Molecular testing results were available for 109 women with high-grade NECC. The genes most frequently mutated were PIK3CA (mutated in 18.5% of patients), TP53 (17.4%), and MYC (14.5%). Other targetable alterations identified were alterations in KIT (7.3%), KRAS (7.3%), and PTEN (7.3%). Women with tumors having an RB1 alteration (6.4%) had a median overall survival (OS) of 13 months, compared to 26 months for women with tumors that did not have an RB1 alteration (p=0.003). None of the other genes evaluated were shown to be associated with OS. CONCLUSION: Although no individual alteration was found in a majority of tumor specimens from patients with high-grade NECC, a large proportion of women with this disease will have at least one targetable alteration. Treatments based on these gene alterations may offer additional targeted therapies for women with recurrent disease, who currently have very limited therapeutic options. Patients with tumors that harbor RB1 alterations have decreased OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCarcinoma, NeuroendocrineHumansFemaleCervix UteriMutationPrognosisUbiquitin-Protein LigasesRetinoblastoma Binding Proteins

Stichwörter der Autor:innen

Cervical CancerNeuroendocrine Carcinoma

Substanzen

RB1 protein, humanUbiquitin-Protein LigasesRetinoblastoma Binding Proteins

Autor:innen und Institutionen

  • Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. aflegarreta@mdanderson.org.
  • Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

ORCID-Profile: Alejandra Flores Legarreta, Gloria Salvo, Naomi R Gonzales, Gary Chisholm, R Tyler Hillman, Michael Frumovitz

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Flores Legarreta, A., Salvo, G., Gonzales, N. R., Chisholm, G., Hillman, R. T., & Frumovitz, M. (2023). RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2023.34.e50

Vancouver

Flores Legarreta A, Salvo G, Gonzales NR, Chisholm G, Hillman RT, Frumovitz M. RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. Journal of Gynecologic Oncology. 2023. doi:10.3802/jgo.2023.34.e50

BibTeX
@article{FloresLegarreta2023,
  author = {Flores Legarreta, Alejandra and Salvo, Gloria and Gonzales, Naomi R and Chisholm, Gary and Hillman, R Tyler and Frumovitz, Michael},
  title = {RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study},
  journal = {Journal of Gynecologic Oncology},
  year = {2023},
  doi = {10.3802/jgo.2023.34.e50}
}
Kostenlos starten →